Skip to main content

Market Overview

10 Hottest Stocks From October 31, 2018

Share:

This list of stocks was generated by tracking the most popular ticker searches on the Benzinga Pro real-time news platform.

Readers can rely on this daily list to offer insight into which stocks retail investors are most interested in during a given trading session. In addition to providing the list itself, this article offers a quick glimpse into why a certain stock may be trending.

  • Shares of Facebook, Inc. (NASDAQ: FB) were up 4.09 percent to $152.20 after the company reported Q3 earnings.
  • General Electric Company (NYSE: GE) shares were down 1.28 percent to $10.05. Moody’s Investors Service downgraded the company’s rating.
  • Shares of Achieve Life Sciences, Inc. (NASDAQ: ACHV) fell 1.46 percent to $2.02. The company on Tuesday announced the initiation of a Phase 2b trial of ORCA-1; A program aimed to evaluate the effectiveness of cytisinicline for smoking cessation..
  • Electro Scientific Industries, Inc. (NASDAQ: ESIO) shares rose 1.79 percent to $29.02. The company on Tuesday reported strong earnings as well as an impending acquisition by MKS Instruments.
  • Shares of Apple Inc. (NASDAQ: AAPL) rose 2.85 percent to $219.41 after the tech giant released a new line of products, like the MacBook Air and the new iPad Pro.
  • Take-Two Interactive Software, Inc. (NASDAQ: TTWO) shares surged 4.17 percent to $129.18 in light of success surrounding “Red Dead Redemption 2.”
  • Shares of Daxor Corp. (NYSE: DXR) fell 24.43 percent to $6.65. On Tuesday, the company announced new data in the Journal of the American College of Cardiology.
  • Strongbridge Biopharma plc. (NASDAQ: SBBP) shares rose 58.02 percent to $6.40 as the company entered into an agreement to acquire the U.S. and Canadian rights to Macrilen.
  • Shares of Under Armour, Inc. (NYSE: UA) fell 5.48 percent to $19.82 after rising nearly 30 percent Tuesday following earnings.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares rose 12.5 percent to $0.72 after announcing the Phase 3 study of its treatment for PTSD.
 

Related Articles (GE + FB)

View Comments and Join the Discussion!

Posted-In: 10 hottest stocks market moversNews After-Hours Center Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com